The extended Metabolic Signalling Set covers incretin and mitochondrial compounds for experiments on insulin signalling, glucose handling and lipid metabolism. Tirzepatide, CJC-1295 No DAC, Ipamorelin, 5-Amino-1MQ and MOTS-C are supplied together at a lower cost than ordering separately.
Metabolic signalling research set
A combination of incretin and metabolic compounds for experiments examining insulin signalling, glucose handling and lipid metabolism in cell models.
Research profiles: Tirzepatide, CJC-1295, Ipamorelin, 5-Amino-1MQ and MOTS-C
What is tested in this set
This set contains five products, each supplied in its own vial and each tested on its own. The table lists the published result for every component.
| Component | Purity | Laboratory | Analysed | Certificate |
|---|---|---|---|---|
| Tirzepatide | 99.74% | Janoshik Analytical | 24 Sep 2026 | View |
| CJC-1295 No DAC | 99.46% | Janoshik Analytical | 9 Jul 2026 | View |
| Ipamorelin | 99.71% | Janoshik Analytical | 9 Jul 2026 | View |
| 5-Amino-1MQ | 99.41% | Janoshik Analytical | 11 Nov 2025 | View |
| MOTS-C | 99.28% | Janoshik Analytical | 24 Sep 2026 | View |










